Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Predict S.P.A. Class B ( (IT:PRE) ) has issued an announcement.
Predict S.p.A. announced its participation in the ‘Next Gems 2025’ equity conference, a significant event for Italian small-cap companies, aiming to enhance visibility among investors. The conference will provide Predict an opportunity to showcase its innovative healthcare technologies and strengthen its market position, potentially attracting new investments and partnerships.
The most recent analyst rating on (IT:PRE) stock is a Buy with a EUR1.45 price target. To see the full list of analyst forecasts on Predict S.P.A. Class B stock, see the IT:PRE Stock Forecast page.
More about Predict S.P.A. Class B
Predict S.p.A., founded in 2008 in Bari, is an innovative SME in the healthcare sector, specializing in in vivo diagnostics through ultrasound and radiological equipment distribution, and developing technologies in breath analysis and digital healthcare. The company is organized into four Strategic Business Units focusing on diagnostic imaging, breath analysis, and digital healthcare solutions, including artificial intelligence and augmented reality technologies.
Average Trading Volume: 32,086
Technical Sentiment Signal: Strong Buy
For a thorough assessment of PRE stock, go to TipRanks’ Stock Analysis page.